首页> 外文期刊>Irish journal of medical science >Evaluating the perioperative safety of laparoscopic radical nephrectomy for large, non-metastatic renal tumours: a comparative analysis of T1-T2 with T3a tumours
【24h】

Evaluating the perioperative safety of laparoscopic radical nephrectomy for large, non-metastatic renal tumours: a comparative analysis of T1-T2 with T3a tumours

机译:评估大型非转移性肾肿瘤腹腔镜自由基肾切除术的围手术期安全性:T3A肿瘤T1-T2的比较分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective With increasing surgeon experience, the use of laparoscopic radical nephrectomy (LRN) in large and locally advanced renal tumours (T3a) is gaining favour in urological practice. There are limited studies reporting surgical outcomes in such groups. The aim of this study was to review our experience with LRN in these patients. Methods Data was retrospectively collected on 201 consecutive patients who underwent LRN for renal cancer by a single surgeon. Perioperative parameters assessed were age, gender, American Society of Anaesthesiologists score (ASA), waist circumference, tumour size, specimen size, histological subtypes, anaesthetic duration, operative approach and technique, surgery duration, blood loss, pre and postoperative renal function, complication rate and duration of hospital stay. Results Of 201 patients undergoing LRN, 43 (21%) patients had T3a tumours (group 2). The remaining 158 (79%) patients had T1 tumours (group1). Mean tumour size in group 2 was 12.2?cm. Renal cell carcinoma (RCC) was more common in males than females (131/201; 65%). Patients with T3a disease were more likely to have an ASA score of 2 (37/201; 18%). In the majority of patients across both groups, LRN was completed using a 3-port approach (173/201; 86%). There were no significant differences between groups in terms of mean anaesthetic duration, average surgical time, average estimated blood loss, complication rate and mean hospital stay. Conclusion Our study shows that LRN has equivalent perioperative outcomes and safety in larger and locally advanced renal tumours.
机译:目的随着外科医生经验的增加,在大型和局部晚期肾肿瘤(T3A)中使用腹腔镜自由基肾切除术(LRN)在泌尿外科实践中获得了青睐。有限的研究报告这些群体中的手术结果。本研究的目的是审查我们对这些患者的LRN的经验。方法回顾性地收集数据,由单个外科医生接受肾癌的LRN的2011连续患者。评估的围手术期参数是年龄,性别,美国麻醉学士学家评分(ASA),腰围,肿瘤大小,样本尺寸,组织学亚型,麻醉持续时间,手术持续时间,失血,预肾功能,并发症住院住院的速度和持续时间。结果201例患者,43例,43例(21%)患者具有T3A肿瘤(第2组)。剩下的158例(79%)患者具有T1肿瘤(Group1)。第2组中的平均肿瘤大小为12.2℃。肾细胞癌(RCC)比女性更常见,而不是女性(131/201; 65%)。 T3A疾病的患者更有可能具有2(37/201; 18%)的ASA得分。在两组患者的大多数患者中,使用3端口方法(173/201; 86%)完成了LRN。在平均麻醉持续时间,平均手术时间,平均估计失血,并发症率和平均住院持续性方面没有显着差异。结论我们的研究表明,LRN在较大和局部晚期肾肿瘤中具有相同的围手术期结果和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号